Based on the Vaxcyte Inc stock forecast from 8 analysts, the average analyst target price for Vaxcyte Inc is USD 135.09 over the next 12 months. Vaxcyte Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Vaxcyte Inc is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, Vaxcyte Inc’s stock price was USD 88.54. Vaxcyte Inc’s stock price has changed by +1.97% over the past week, -21.41% over the past month and +80.69% over the last year.
No recent analyst target price found for Vaxcyte Inc
No recent average analyst rating found for Vaxcyte Inc
Company Overview Vaxcyte Inc
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California. Read Less
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumo...Read More
Frequently Asked Questions About Vaxcyte Inc (PCVX) Stock
Based on ratings from 8 analysts Vaxcyte Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 11 buy, sell and hold ratings.
Unfortunately we do not have enough data on PCVX's stock to indicate if its a good dividend stock.
Based on targets from 8 analysts, the average taret price for PCVX is USD 135.09 over the next 12 months. The maximum analyst target price is USD 163 while the minimum anlayst target price is USD 95.
Unfortunately we do not have enough data on PCVX's stock to indicate if its overvalued.
The last closing price of PCVX's stock was USD 88.54.
The most recent market capitalization for PCVX is USD 13.28B.
Based on targets from 8 analysts, the average taret price for PCVX is projected at USD 135.09 over the next 12 months.
This means that PCVX's stock price may go up by +52.58% over the next 12 months.
We can't find any ETFs which contains Vaxcyte Inc's stock.
As per our most recent records Vaxcyte Inc has 254 Employees.
Vaxcyte Inc's registered address is 825 Industrial Road, San Carlos, CA, United States, 94070.
You can get more information about it from Vaxcyte Inc's website at https://vaxcyte.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Vaxcyte Inc (PCVX) Stock
Based on ratings from 8 analysts Vaxcyte Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 11 buy, sell and hold ratings.
Unfortunately we do not have enough data on PCVX's stock to indicate if its a good dividend stock.
Based on targets from 8 analysts, the average taret price for PCVX is USD 135.09 over the next 12 months. The maximum analyst target price is USD 163 while the minimum anlayst target price is USD 95.
Unfortunately we do not have enough data on PCVX's stock to indicate if its overvalued.
The last closing price of PCVX's stock was USD 88.54.
The most recent market capitalization for PCVX is USD 13.28B.
Based on targets from 8 analysts, the average taret price for PCVX is projected at USD 135.09 over the next 12 months.
This means that PCVX's stock price may go up by +52.58% over the next 12 months.
We can't find any ETFs which contains Vaxcyte Inc's stock.
As per our most recent records Vaxcyte Inc has 254 Employees.
Vaxcyte Inc's registered address is 825 Industrial Road, San Carlos, CA, United States, 94070.
You can get more information about it from Vaxcyte Inc's website at https://vaxcyte.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for PCVX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
